BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22856328)

  • 21. [Oxidative stress and molecular biology in ulcerative colitis and cancer].
    Romero Alvira D; Villalón Rico C; Cornago Sánchez A; Gotor Lázaro MA; López García C; Roche Collado E
    Rev Esp Enferm Dig; 1997 Jun; 89(6):463-73. PubMed ID: 9303611
    [No Abstract]   [Full Text] [Related]  

  • 22. Overt Increase of Oxidative Stress and DNA Damage in Murine and Human Colitis and Colitis-Associated Neoplasia.
    Frick A; Khare V; Paul G; Lang M; Ferk F; Knasmüller S; Beer A; Oberhuber G; Gasche C
    Mol Cancer Res; 2018 Apr; 16(4):634-642. PubMed ID: 29378905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular profiling of ulcerative colitis-associated neoplastic progression.
    Colliver DW; Crawford NP; Eichenberger MR; Zacharius W; Petras RE; Stromberg AJ; Galandiuk S
    Exp Mol Pathol; 2006 Feb; 80(1):1-10. PubMed ID: 16277983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic inflammatory bowel disease and cancer.
    Pohl C; Hombach A; Kruis W
    Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A specific genetic alteration on chromosome 6 in ulcerative colitis-associated colorectal cancers.
    Ezaki T; Watanabe M; Inoue N; Kanai T; Ogata H; Iwao Y; Ishii H; Hibi T
    Cancer Res; 2003 Jul; 63(13):3747-9. PubMed ID: 12839969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripheral lymphocyte DNA damage and oxidative stress in patients with ulcerative colitis.
    Aslan M; Nazligul Y; Bolukbas C; Bolukbas FF; Horoz M; Dulger AC; Erdur FM; Celik H; Kocyigit A
    Pol Arch Med Wewn; 2011; 121(7-8):223-9. PubMed ID: 21677607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of ulcerative colitis and its associated colorectal neoplasia as a model of the organ-specific chronic inflammation-carcinoma sequence.
    Okayasu I
    Pathol Int; 2012 Jun; 62(6):368-80. PubMed ID: 22612505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preventive effect of fluvastatin on ulcerative colitis-associated carcinogenesis in mice.
    Suzuki S; Tajima T; Sassa S; Kudo H; Okayasu I; Sakamoto S
    Anticancer Res; 2006; 26(6B):4223-8. PubMed ID: 17201137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T; May B; Pfisterer O; Müller KM; Brasch F
    Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer surveillance in inflammatory bowel disease: new molecular approaches.
    Risques RA; Rabinovitch PS; Brentnall TA
    Curr Opin Gastroenterol; 2006 Jul; 22(4):382-90. PubMed ID: 16760754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
    Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
    Gut; 2009 Sep; 58(9):1226-33. PubMed ID: 19251712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypermethylation of the p14(ARF) gene in ulcerative colitis-associated colorectal carcinogenesis.
    Sato F; Harpaz N; Shibata D; Xu Y; Yin J; Mori Y; Zou TT; Wang S; Desai K; Leytin A; Selaru FM; Abraham JM; Meltzer SJ
    Cancer Res; 2002 Feb; 62(4):1148-51. PubMed ID: 11861396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant methylation of the HPP1 gene in ulcerative colitis-associated colorectal carcinoma.
    Sato F; Shibata D; Harpaz N; Xu Y; Yin J; Mori Y; Wang S; Olaru A; Deacu E; Selaru FM; Kimos MC; Hytiroglou P; Young J; Leggett B; Gazdar AF; Toyooka S; Abraham JM; Meltzer SJ
    Cancer Res; 2002 Dec; 62(23):6820-2. PubMed ID: 12460892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Folate and colorectal carcinogenesis: is DNA repair the missing link?
    Choi SW; Mason JB
    Am J Gastroenterol; 1998 Nov; 93(11):2013-6. PubMed ID: 9820367
    [No Abstract]   [Full Text] [Related]  

  • 35. Advanced oxidation protein products: a novel marker of oxidative stress in ulcerative colitis.
    Baskol M; Baskol G; Koçer D; Ozbakir O; Yucesoy M
    J Clin Gastroenterol; 2008 Jul; 42(6):687-91. PubMed ID: 18574392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
    Szewczuk MR; Depew WT
    Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular carcinogenesis in ulcerative colitis-associated and sporadic colorectal carcinoma--differences and similarities].
    Aust DE; Baretton GB; Waldman FM; Löhrs U
    Verh Dtsch Ges Pathol; 1999; 83():130-8. PubMed ID: 10714203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accumulation of mitochondrial DNA mutation with colorectal carcinogenesis in ulcerative colitis.
    Nishikawa M; Oshitani N; Matsumoto T; Nishigami T; Arakawa T; Inoue M
    Br J Cancer; 2005 Aug; 93(3):331-7. PubMed ID: 15956973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Risk of cancer in chronic inflammatory bowel diseases].
    Fischbach W
    Leber Magen Darm; 1992 May; 22(3):96-101. PubMed ID: 1625513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Over-expression of p53 protein in neoplastic changes in ulcerative colitis: immunohistochemical study.
    Ajioka Y; Watanabe H; Matsuda K
    J Gastroenterol; 1995 Nov; 30 Suppl 8():33-5. PubMed ID: 8563884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.